Könnte ein Zock wert sein !
IBCI Announces Meeting With Federal Agency Concerning Bio-terrorism Set For Monday, February 3, 2003 Government Sets Parameters Yesterday Afternoon for Discussion of Combating Bio-terrorism
ATLANTA, Jan 30, 2003 /PRNewswire via COMTEX/ -- International BioChemical
Industries, Inc. (OTC Bulletin Board: IBCL), formerly known as BioShield
Technologies, Inc., announced that a Federal government agency, requesting
urgency, has scheduled its meeting with IBCI to discuss test data and BioShield
products that will be effective in the war on bio-terrorism. The discussion will
include manufacturing capabilities, good laboratory practices and protocols,
security of the facility and security of internal data files including test
locations and employee confidentiality.
About International BioChemical Industries:
International BioChemical Industries, Inc. is a Norcross, Georgia-based emerging
growth company with the only antimicrobial technology approved by the EPA for
residual kill on hard surfaces up to 28 days. Additional approvals by the EPA
include 5 year residual kill in textiles, approval for use in cosmetics and
approval for fogging. The company's antimicrobial technology is an alternative
to conventional sanitizers, disinfectants, bleaches, biocides or preservatives
primarily because it kills bacteria on contact and can remain active for
extended time periods. To date IBCI has received four U.S. patents and eight EPA
registrations, including the first U.S. germ killer and disinfectant against
Salmonella cholerasuis, Staphylococcus aureus and other microorganisms. The
company has developed several alliances in different industries, such as
healthcare, textiles and storm water.
Further information on IBCI and its line of products can be found by visiting
the firm's web site at www.bioshield.com , or by calling 1-770-925-3653,
Tim Moses.
Safe Harbor/Forward-looking Statements:
Statements in this news release that are not historical are forward- looking
statements. These forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from those
anticipated in any forward-looking statements, all of which are difficult to
predict and many of which are beyond the control of the company, including areas
such as: developing technologies; dependence on collaborative partners; the
inherent complexity and uncertainty regarding the development of products;
early-stage development of IBCI; the result of research and development efforts;
future capital needs; uncertainty of additional funding; government regulations;
and other factors which are detailed in the company's periodic reports and
registration statements filed with the Securities and Exchange Commission. IBCI
does not undertake to revise or update any forward- looking statement to reflect
events or circumstances that may arise after the date hereof. BioShield is a
trademark of IBCI.
SOURCE International BioChemical Industries, Inc.
CONTACT: Tim Moses of International BioChemical Industries, Inc.,
+1-770-925-3653
URL: www.bioshield.com
www.prnewswire.com
chart.bigcharts.com/bc3/quickchart/...51&mocktick=1&rand=7080" style="max-width:560px" >
Meinungen ?
IBCI Announces Meeting With Federal Agency Concerning Bio-terrorism Set For Monday, February 3, 2003 Government Sets Parameters Yesterday Afternoon for Discussion of Combating Bio-terrorism
ATLANTA, Jan 30, 2003 /PRNewswire via COMTEX/ -- International BioChemical
Industries, Inc. (OTC Bulletin Board: IBCL), formerly known as BioShield
Technologies, Inc., announced that a Federal government agency, requesting
urgency, has scheduled its meeting with IBCI to discuss test data and BioShield
products that will be effective in the war on bio-terrorism. The discussion will
include manufacturing capabilities, good laboratory practices and protocols,
security of the facility and security of internal data files including test
locations and employee confidentiality.
About International BioChemical Industries:
International BioChemical Industries, Inc. is a Norcross, Georgia-based emerging
growth company with the only antimicrobial technology approved by the EPA for
residual kill on hard surfaces up to 28 days. Additional approvals by the EPA
include 5 year residual kill in textiles, approval for use in cosmetics and
approval for fogging. The company's antimicrobial technology is an alternative
to conventional sanitizers, disinfectants, bleaches, biocides or preservatives
primarily because it kills bacteria on contact and can remain active for
extended time periods. To date IBCI has received four U.S. patents and eight EPA
registrations, including the first U.S. germ killer and disinfectant against
Salmonella cholerasuis, Staphylococcus aureus and other microorganisms. The
company has developed several alliances in different industries, such as
healthcare, textiles and storm water.
Further information on IBCI and its line of products can be found by visiting
the firm's web site at www.bioshield.com , or by calling 1-770-925-3653,
Tim Moses.
Safe Harbor/Forward-looking Statements:
Statements in this news release that are not historical are forward- looking
statements. These forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from those
anticipated in any forward-looking statements, all of which are difficult to
predict and many of which are beyond the control of the company, including areas
such as: developing technologies; dependence on collaborative partners; the
inherent complexity and uncertainty regarding the development of products;
early-stage development of IBCI; the result of research and development efforts;
future capital needs; uncertainty of additional funding; government regulations;
and other factors which are detailed in the company's periodic reports and
registration statements filed with the Securities and Exchange Commission. IBCI
does not undertake to revise or update any forward- looking statement to reflect
events or circumstances that may arise after the date hereof. BioShield is a
trademark of IBCI.
SOURCE International BioChemical Industries, Inc.
CONTACT: Tim Moses of International BioChemical Industries, Inc.,
+1-770-925-3653
URL: www.bioshield.com
www.prnewswire.com
Meinungen ?
